Press Releases

21st Century Oncology Granted Membership in Radiation Therapy Oncology Group, a Prestigious Cancer Research Cooperative ›

October 29, 2012

SCOTTSDALE, Ariz. – Oct. 29, 2012 – 21st Century Oncology, the nation's premier cancer treatment network and largest radiation therapy provider, has been awarded an affiliate membership in the Radiation Therapy Oncology Group (RTOG). A leading multi-institutional, international clinical cooperative group funded primarily by the National Cancer Institute, the RTOG conducts large-scale clinical trials testing new approaches to many adult malignancies in order to increase the survival and improve the quality of life of patients diagnosed with cancer.

Research Finds Low Toxicity, Favorable Cosmetic Results for Strut-Based Breast Brachytherapy ›

October 29, 2012

(BOSTON, Mass.) – Oct. 29, 2012 – Breast brachytherapy with a strut-based applicator had favorable toxicity rates and cosmetic outcomes, according to research delivered by 21st Century Oncology at the 54th annual meeting of the American Society for Radiation Oncology (ASTRO) - the largest radiation oncology society in the world.

Everblades Announce Details of Inaugural "Sticks and Staches" Kickoff ›

October 23, 2012

ESTERO, Fla. — Oct. 23, 2012 — The Florida Everblades are gearing up for their inaugural “Sticks and Staches” Kickoff this Friday (October 26) when they play host to the South Carolina Stingrays at Germain Arena. Game time is set for 7:30 p.m.

“It’s Better To Know Than Wait Until It’s Too Late” ›

September 12, 2012

SARASOTA, Fla. – Five years ago, 68-year-old Daniel Ferreira joined the one in six men who will be diagnosed with prostate cancer during their lifetime. Determined to be a survivor, Mr. Ferreira turned to one of Florida’s leading prostate cancer physicians, John Sylvester, M.D., a 21st Century Oncology physician practicing in Sarasota.

“I Lost My Father, Knowing I Could Be Next” ›

September 05, 2012

ABBEVILLE, Ala. – When 67-year-old Tallie Martin’s father died from prostate cancer, he made a decision to endeavor not to meet the same fate. Coming from a long line of cancer, the retired Alabama native and outdoor enthusiast knew his risk was high.

"This One's For the Boys!" Race Against Prostate Cancer Looking to Top Last Year's Funds Raised ›

August 27, 2012

LAS VEGAS, Nev.—August 27, 2012—Saturday, September 29th, 2012 will mark the second annual This One’s for the Boys! Two-Mile Walk and Three-Mile Run to benefit 21st Century C.A.R.E. and the Las Vegas Chapter of Us TOO Prostate Cancer Support Group. The event will take place at 8:30 a.m. at the UNLV Track & Field Stadium. Registration for the event will be $25 online or $30 on the day of the event. The first 100 participants will receive an event t-shirt.

21st Century Oncology and Humana Break New Ground with Case Rate Reimbursement Agreement ›

August 07, 2012

FORT MYERS, Fla.—August 7, 2012—21st Century Oncology, the nation’s premier cancer treatment network and largest radiation therapy provider, and Humana Inc. (NYSE: HUM) one of the nation’s leading health care and well-being companies, today announced a national agreement to enact case rate reimbursement for radiation therapy services.

Cancer Consultants-Las Vegas Joins Leading Cancer Care Group, 21st Century Oncology ›

July 09, 2012

July 09, 2012 (Las Vegas, Nev.)—21st Century Oncology – the nation’s premier cancer treatment network and largest radiation therapy provider – is expanding its group of oncology experts with the recent acquisition of Cancer Consultants, a well-established Las Vegas medical oncology and hematology practice. The union adds two new physicians dedicated in the delivery of compassionate care, further growing services in a community that currently includes multiple 21st Century Oncology radiation treatment centers spanning from Las Vegas to Henderson.

When and When Not to Use a PSA Test  ›

June 04, 2012

21st Century Oncology, the country’s largest radiation therapy provider and second largest urology group, responds to the U.S. Preventive Services Task Force (USPSTF) recommendations on the use of the prostate-specific antigen (PSA) test.

To top